United States Securities and Exchange Commission · EDGAR Accession 0001905495-26-000007

Form C-U

Offering Progress Update — Regulation Crowdfunding
Campaign file 020-35964
Issuer CIK 1905495
Raising via CancerVax, Inc.

CancerVax, Inc.

CorporationNVIncorporated 2021Lehi, UTcancervax.com
Progress updateAt the close of the offering, the issuer closed on $903,060.03 and 494,624 number of securities.
A

The Offering

as disclosed in this filing
Common Stock
$2.10
$9,998
$1,235,000
September 1, 2025
Expired 286 days ago
$0max $1,235,000

Target is 1% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn decreasingDebt / assets 1161%6 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold4,245,0383,418,574▲ 24%
Net income(7)(14)▲ burn
Total assets294,703204,105▲ 44%
Cash & equivalents183,505138,209▲ 33%
Accounts receivable00
Short-term debt3,421,1471,684,944▲ 103%
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-35964 · all filings under this campaign
Loading campaign history…